Bing

MUMBAI: Sun Pharmaceutical Industries, India's largest drug maker, said it would acquire the opiates business of British drug maker GlaxoSmithKline (GSK ... 1.8% to Rs 941.85 at the close on the National Stock Exchange and were among the top gainers ...
The Economic Times · 3/4/2015
GSK sells HIV medicines through its majority-owned ViiV Healthcare unit, which it had been considering for a stock market listing, until a change of tack on May 6. Its investment at Chapel Hill is separate from ViiV, although ViiV will play an advisory role.
The Business Insider · 5/11/2015
The reverse stock split, which will allow the company to maintain ... The FDA has expanded the approved use of Promacta, co-discovered by GlaxoSmithKline plc (GSK) and Ligand Pharmaceuticals Inc. (LGND) for children 1 year of age and older with …
Realtime Business News · 8/25/2015
Stock that moved up in this period and where FPIs too increased their stakes include Astra Zeneca, Glaxosmithkline, Sanofi, Unichem, Jubilant Life, Ajantha Pharma, Biocon and Glemmark Pharma.
The Hindu Business Line · 8/30/2015
stocks
Such action includes the Foreign Corrupt Practices Act (FCPA), implemented in 1977 in the US to prohibit bribery ... GSK made an estimated $150m in illegal profits, the BBC reports, and the fine marked the biggest ever seen in the country’s history.
worldfinance.com · 3/6/2015
We have a trifecta of recent hedge fund buying activity for you to ... and GlaxoSmithKline plc (ADR) (NYSE:GSK). Eagle Pharmaceuticals Inc (NASDAQ:EGRX) has been a relatively stable stock since its IPO in February, save for a couple of valleys in May ...
INSIDER MONKEY · 2/4/2015
as per a stock market disclosure. In April this year, GSK and Novartis agreed to form a global consumer healthcare JV in which GSK will own majority stake. The transaction is expected to be completed in the first half of 2015 following which Ahmed will ...
VC Circle · 10/8/2014
GSK is tapping into the latest expertise by creating an HIV Cure center with the University of North Carolina ... which it had been considering for a stock market listing, until a change of tack on May 6. Its investment at Chapel Hill is separate from ...
FOX News · 5/11/2015
In other words, a successful Ebola vaccine won’t be a needle mover for Merck’s stock. Let’s see why ... there could be around 3 potential vaccine players including J&J and GSK, we estimate that these vaccine makers may collectively target around ...
Trefis · 8/21/2015
GlaxoSmithKline Plc rose 1.9 per cent ... while volume on the measure was 19 per cent above its 30-day average. The Nikkei 225 Stock Average lost 0.4 per cent to 18,095.40. Daio Paper plunged 18 per cent after …
Australian Financial Review · 5 hours ago

GlaxoSmithKline

Company
GlaxoSmithKline plc is a British multinational pharmaceutical company headquartered in Brentford, London. It was the world'…
GlaxoSmithKline plc is a British multinational pharmaceutical company headquartered in Brentford, London. It was the world's sixth-largest pharmaceutical company in 2014, after Pfizer, Novartis, Sanofi, Hoffmann-La Roche and Merck. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham.
Data from: Wikipedia